Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Proteasome inhibitor delanzomib for use in the treatment of lupus

Proteasome inhibitor delanzomib for use in the treatment of lupus

US Patent 9340559 · Granted May 17, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising angiogenic factors and methods of use thereof2020
Methods of treating various cancers using an AXL/cMET inhibitor in combination w2018
Compositions comprising angiogenic factors and methods of use thereof2018
Compositions comprising angiogenic factors and methods of use thereof2018
Compositions comprising angiogenic factors and methods of use thereof2016
Compositions and methods for prevention of escape mutation in the treatment of H2015
Treatment of chronic inflammation with a 1,2,4-triazolo [1,5a] pyridine derivati2015
Janus kinase 2 (JAK2) inhibitor for the treatment of lupus2015
Compositions and methods for prevention of escape mutation in the treatment of H2015
Compositions comprising angiogenic factors and methods of use thereof2014
Fused pyrrolocarbazoles2013
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereo2012